Fleury SA, founded in 1926 and headquartered in São Paulo, Brazil, is a prominent healthcare company focused on providing high-quality diagnostic services. The company specializes in medical laboratory tests and imaging services, catering to both individual consumers and healthcare providers.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| FLRYSA 10.89% 2028-10-23 BRLFleury SA | Brazil | 2028-10-23 | 10.890 | 9.81 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Fleury SA began issuing bonds in the early 2000s to finance its expansion and operational improvements, and it has since established a solid reputation in the debt market. Noteworthy issuances include a R$ 500 million bond in 2015 aimed at enhancing service capabilities and a subsequent issuance in 2021 that attracted strong investor interest due to its competitive yields compared to industry standards. As of late 2023, Fleury's bonds have been performing favorably, demonstrating resilience in a fluctuating market, with yields that remain attractive to retail investors.